MedTrace Logo

Use of Platelet Rich Plasma in the Management of Acute Hamstring Muscle Strain Injury

NCT01812564 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2015-01-14

No results posted yet for this study

Summary

The purpose of this study is to evaluate the therapeutic benefit of utilizing complex growth factor preparations (Platelet Rich Plasma (PRP) in the management of acute hamstring injuries.

The hypothesis is that the time to return to sport is shorter in the patient group treated with Complex Growth Factor Preparations (PRP) in combination with exercise therapy in comparison with 2 control groups:

* the patient group treated with Platelet Poor Plasma (PPP) injections in combination with exercise therapy (control injection AND usual care).
* the patient group treated with exercise therapy (usual care)

Conditions

  • Acute Hamstring Muscle Strain Injury

Interventions

BIOLOGICAL

Platelet Poor Plasma (PPP)

BIOLOGICAL

Platelet Rich Plasma (PRP)

Sponsors & Collaborators

  • Aspetar

    lead OTHER

Principal Investigators

  • Hakim Chalabi, MD · Aspetar

  • Bruce Hamilton, MD · Aspetar

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2013-10-31
Completion
2014-10-31

Countries

  • Qatar

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01812564 on ClinicalTrials.gov